Artificial cell wall system based on DNA logic gate and application thereof
By combining a DNA logic gate-driven hydrogel barrier with a low concentration of polyol protectant, the problems of mechanical damage and DMSO toxicity in cell cryopreservation are solved, achieving cell cryopreservation with high survival rate and functional recovery, suitable for a variety of cell types.
Patent Information
- Application Number
- CN202511183578.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-08-22
- Publication Date
- 2025-12-05
AI Technical Summary
Existing cell cryopreservation technologies suffer from mechanical freezing damage, loss of cell function, and DMSO toxicity, and lack universality across cell types, making it difficult to meet the cryopreservation needs of different cell types.
Using an artificial cell wall system based on DNA logic gates, a hydrogel barrier is formed by triggering a hybridization chain reaction through probes and linkers. Combined with a low-concentration polyol-based permeable cryoprotectant, DMSO-free cryopreservation is achieved, and signaling pathways are activated through the DNA logic framework to promote cell function recovery.
It achieves DMSO-free cryopreservation, protects cell membrane integrity, improves cell survival and proliferation capacity, adapts to the cryopreservation needs of various cell types, and activates cell function recovery.
Smart Images

Figure CN121058639A_ABST
Abstract
Description
TECHNICAL FIELD
[0001] The application belongs to the technical field of cell processing, and particularly relates to an artificial cell wall system based on a DNA logic gate and application thereof. BACKGROUND
[0002] In cell therapy, regenerative medicine and tissue engineering, the cryopreservation of cells is a key link. However, the current cell cryopreservation faces two core problems difficult to break through: ① In the freezing process, the formation of ice crystals will directly damage the cell membrane and organelle structure, causing mechanical freezing injury. ② Even if the cells are successfully resuscitated, there are often problems such as cell cycle arrest and significant decrease in proliferation and migration ability, resulting in loss of cell function after resuscitation. As a widely used cryoprotectant, dimethyl sulfoxide (DMSO) can effectively reduce the damage of ice crystals to cells, but it has neurotoxicity and potential cytotoxicity problems, and is difficult to completely remove after cell resuscitation, thereby affecting the safety and effectiveness of subsequent cell application.
[0003] In view of the limitations of DMSO, a variety of DMSO-free alternatives have been reported, but there are still obvious technical defects. For example, low-toxicity organic solvents (such as ethylene glycol, propylene glycol, etc.) can be used as cryoprotectants, but they usually need to be used at a concentration as high as 15%, which seriously affects the mitochondrial function of cells and easily leads to energy metabolism disorder of cells. For example, ice growth inhibitors (such as antifreeze proteins, etc.) can regulate ice crystal growth to some extent, but they cannot be effectively combined with the cell membrane of mammals, and it is difficult to provide substantial protection to the fragile cell membrane. Although synthetic extracellular matrix can provide physical support for cells, it will hinder the exchange of substances and signal transduction between cells and the outside world, inhibit cell proliferation signals, and is not conducive to the functional recovery of cells after resuscitation. In addition, DNA hydrogel wrapping technology has been proposed, which forms a cell wall template synthesis system by constructing a DNA network structure to provide physical barrier protection for cells. However, the current technology only focuses on the physical protection of cells, and has not been expanded to the cryopreservation scenario, and completely does not involve the functional activation strategy after resuscitation, so that the "high survival rate and functional integrity" of cell cryopreservation cannot be achieved.
[0004] In general, the current cell cryopreservation technology still has the problem of safety risk caused by toxicity, and it is difficult to balance physical protection and biological function recovery. In addition, the current cell cryopreservation technology lacks cell type universality, mainly manifested in that the fixed formula cannot be customized to adapt to different cell types, and a single cryopreservation system cannot meet the differentiated cryopreservation needs of immune cells and tumor cells. SUMMARY
[0005] Therefore, the primary purpose of the present application is to provide an artificial cell wall system based on DNA logic gates, which can bring a technical breakthrough to cell cryopreservation and realize DMSO-free cryopreservation. Not only can the integrity of the cell membrane be protected during the freezing process, but also has a biological activation function, so that the recovered cells not only survive, but also have a proliferation ability beyond fresh cells. In addition, the cryopreserved cell method based on the artificial cell wall system has universality, and the corresponding artificial cell wall system can be customized for different cell types, and can adapt to the cryopreservation needs of various cell types.
[0006] In order to achieve the above purpose, the present application adopts the following technical solutions: One aspect of the present application discloses an artificial cell wall system based on DNA logic gates, comprising: probe 1 and probe 2, the structure of probe 1 is Apt-S-T1, and the structure of probe 2 is T2-S-Apt, wherein Apt is a nucleic acid aptamer targeting the receptor of the cell membrane to be treated, S is a spacer sequence, T1 and T2 are first and second toe sequences, respectively; a linker for triggering a hybridization chain reaction to form a stable DNA structure; hairpin 1 and hairpin 2, the end of the hairpin 1 or the hairpin 2 is modified with a hydrogel skeleton material; and a crosslinking agent for initiating crosslinking of the hydrogel skeleton material to form a hydrogel.
[0007] Another aspect of the present application discloses the application of the aforementioned artificial cell wall system in cell cryopreservation or cell regeneration.
[0008] Another aspect of the present application discloses a cell cryopreservation system, comprising: the aforementioned artificial cell wall system; and a permeable cryoprotective additive with a concentration not exceeding 10%, which is a polyol.
[0009] Another aspect of the present application discloses a cell cryopreservation method, comprising the following steps: cryopreserving the cells to be cryopreserved in a cell culture medium containing the aforementioned cell cryopreservation system.
[0010] The beneficial effects of the present application are: The artificial cell wall system provided by the application is based on a DNA logic gate design, and corresponding aptamers are customized for different types of cells to obtain corresponding probes. A toehold region is introduced into the probes, and a toehold-mediated hybridization chain reaction (HCR) is performed to realize the construction of a DNA logic framework. At the same time, an effective hydrogel barrier is constructed by modifying the hydrogel material to form an artificial cell wall. The subsequent hydrogel can be degraded, the DNA logic framework can induce receptor dimerization, activate the signal pathway, and complete the functional activation.
[0011] The cell cryopreservation method provided by the application has the following advantages: ①DMSO dependence is eliminated: through the synergistic effect of the artificial cell wall (ACW) and the low-concentration polyhydric alcohol osmotic cryoprotective additive (concentration ≤ 10%), the complete DMSO-free cryopreservation of cells is realized, thereby avoiding the toxicity risk caused by the use of DMSO. ②Dual-function integration is realized: physical protection is provided by the physical protection layer formed by the artificial cell wall (ACW) to resist the mechanical damage and osmotic shock caused by ice crystals during the freezing process, and the integrity of the cell structure is ensured; at the same time, the biological activation function is provided by the DNA logic framework to induce receptor dimerization and activate the downstream Akt signal pathway to promote the proliferation and migration of the cells after resuscitation. ③The universality is improved: the programmability of the DNA aptamer is used to customize the corresponding artificial cell wall (ACW) system scheme for different cell types, so that the system can adapt to the cryopreservation needs of various cell types. ④Functional recovery is realized: the cells resuscitated after cryopreservation not only can survive, but also have a proliferation ability beyond that of fresh cells. BRIEF DESCRIPTION OF DRAWINGS
[0012] Figure 1 FIG. 1 is a schematic diagram of the synthesis of an artificial cell wall (ACW) in a typical embodiment of the application, wherein: Figure 1 In FIG. 1A, A is a display of an associated toehold activation mechanism based on double aptamers, a linker (Linker) is combined with Apt-S-T1 and T2-S-Apt to form an associated toehold for hybridization chain reaction (HCR) based on double aptamers; Figure 1 In FIG. 1B, B is a display of DNA logic framework recognition, HCR reaction, and calcification on living cells to form an ACW; Figure 1 In FIG. 1C, C is a display of the additional protection capability of the ACW attached to the cell membrane during the cryopreservation process; Figure 1 In FIG. 1D, D is a display of the activation of the downstream signal by the DNA logic framework and the promotion of the proliferation after thawing.
[0013] Figure 2 FIG. 2 is a characterization result of the DNA logic framework on the target cell membrane, wherein: Figure 2 Figure 1A is a 10% gel electrophoresis image of H1 and H1-Alg; Figure 2 Figure 2B is a gel analysis of DNA logic framework by toehold-mediated activation in buffer, lane 1 is DNA molecular mass standard, lane 2 is TCO1-S-T1, lane 3 is T2-S-TCO1, lane 4 is Linker, lane 5 is H2, lane 6 is H1-Alg, lane 7 is TCO1-S-T1+T2-S-TCO1+Linker, lane 8 is TCO1-S-T1+T2-S-TCO1+Linker+H2+H1-Alg; Figure 2 Figure 3C is an aptamer binding competition assay on Jurkat T cells, gray represents Jurkat T cells; green and magenta: left is TCO1-S-T1-FAM incubated with Jurkat T cells, right is T2-S-TCO1-Cy3 incubated with Jurkat T cells; red: TCO1-S-T1 and T2-S-TCO1 incubated with Jurkat T cells. Aptamer concentration is 400 nM.
[0014] Figure 2 Figure 4D is a fluorescence microscope analysis of DNA logic framework for cell targeting. Blue: DAPI; green: Apt-S-T1-FAM; magenta: T2-S-Apt-Cy3; red: H2-Cy5. Scale bar: 20 μm.
[0015] Figure 3 Figure 5 is a characterization of artificial cell wall on cell membrane surface, wherein: Figure 3 Figure 6A is flow cytometry (Ca2+ion is stained with calcein, which is an indicator for calcium ion), left and middle panels each contain three vertical parts, from top to bottom, represent Jurkat T cell group, non-ACW group and ACW group, respectively. Non-ACW group: TCO1-S-T1+T2-S-TCO1+Linker+H1-Alg+H2-Cy5; ACW group: TCO1-S-T1+T2-S-TCO1+Linker+H1-Alg+H2-Cy5+CaCl2; Figure 3Figure 6. The fluorescence microscope images of Jurkat T cells, HeLa cells and PL45 cells. Blue: DAPI; Red: H2-Cy5; Green: Calcein. Jurkat T cells: TCO1-S-T1+T2-S-TCO1+Linker+H1-Alg+H2-Cy5; HeLa cells: MET-S-T1+T2-S-MET+Linker+H1-Alg+H2-Cy5; PL45 cells: MET-S-T1+T2-S-XQ-2d+Linker+H1-Alg+H2-Cy5. Scale bar: 20 μm; Figure 3 Figure 7. The scanning electron microscope (SEM) images of Jurkat T@ACW. Scale bar: 20 μm. Figure 3 Figure 8. The transmission electron microscope (TEM) images of Jurkat T@ACW. Scale bar: 200 nm.
[0016] Figure 4 Figure 9. The results of the physicochemical properties and physiological functions of the cells after cryopreservation. Among them: Figure 4 Figure 10. The cooling process of natural cells and ACW-treated cells. A. Figure 4 Figure 11. The quantitative data of the immediate survival rate and the survival rate after cryopreservation of Jurkat T, HeLa and PL45 cells. (*: P<0.0001 ); Figure 4 Figure 12. The optical images of the growth of Jurkat T cells after 24 hours of culture after cryopreservation. Scale bar: 50 μm. Figure 4 Figure 13. The quantitative data of the adhesion efficiency of HeLa cells and PL45 cells after 24 hours of culture after cryopreservation. (*: P<0.05 ).
[0017] Figure 5 Figure 14. The function of artificial cell wall in regulating cell behavior. Among them: Figure 5 Figure 15. The schematic diagram of DNA hybridization activating wound healing in scratch experiment. A. Figure 5 Figure 16. The artificial regulation of MET downstream Akt phosphorylation and cell migration in HeLa cells after different treatments. B. Figure 5 Figure 17. The artificial regulation of wound healing. The migration ability of HeLa cells after different treatments. The migration ability of cells is reflected by the wound healing efficiency. The pictures were taken at 0 hour, 24 hours and 48 hours. The white line represents the boundary between the monolayer cells and the scratch area not covered by cells. Scale bar: 200 μm. Figure 5 Figure 9C shows the statistical analysis of relative wound closure rate of three parallel samples. Data are expressed as mean ± standard deviation (*: P<0.05 Figure 5 Figure 9E shows the MET signaling pathway activation triggered by DNA logic gate in HeLa cells by Western blot analysis. Figure 5 Figure 9F shows the quantitative data of proliferation rate of HeLa cells after cryopreservation. (Fresh: untreated; 10% glycol: treated with 10% glycol; DNA logic gate: treated with DNA logic gate; Degraded: treated with degraded DNA logic gate). DETAILED DESCRIPTION
[0018] The embodiments of the present application will be described below clearly and completely. The technical solutions in the embodiments described below are exemplary and only possible technical implementations of the present application, not all possible implementations. Those skilled in the art can obtain other embodiments by combining the embodiments of the present application without creative labor, and these embodiments are also within the protection scope of the present application.
[0019] The first aspect of the present application discloses an artificial cell wall system based on DNA logic gate, comprising: probe 1 and probe 2, the structure of probe 1 is Apt-S-T1, and the structure of probe 2 is T2-S-Apt, wherein Apt is a nucleic acid aptamer targeting the membrane receptor of the cell to be treated, S is a spacer sequence, and T1 and T2 are respectively a first toe end sequence and a second toe end sequence; a linker for triggering a hybridization chain reaction to form a stable DNA structure; hairpin 1 and hairpin 2, the end of the hairpin 1 or the hairpin 2 is modified with a hydrogel skeleton material; and a crosslinking agent for initiating crosslinking of the hydrogel skeleton material to form a hydrogel.
[0020] In the present application, the term “DNA logic gate” is a programmable molecular circuit constructed by DNA strand displacement reaction, which is used for cell-specific recognition and signal regulation.
[0021] The term “artificial cell wall (ACW)” is a biomimetic structure composed of DNA logic gate and hydrogel, which wraps the cell to provide physical protection and biological function activation.
[0022] The term “associated toe end activation” is a DNA programming mechanism that triggers a spatiotemporally controllable hybridization chain reaction (HCR) through multiple toe end regions.
[0023] Specifically, the application constructs an artificial cell wall system based on DNA logic gates, which drives the construction of artificial cell walls by means of DNA logic gates, and successfully realizes the cryopreservation under the condition of no DMSO and the functional activation after resuscitation. The specific working principle is as follows: At the cell recognition stage, the aptamer-spacer-toehold probe (Apt-S-Tn) can accurately target the membrane receptor, laying the foundation for the subsequent process. After entering the self-assembly stage, the linker can bridge adjacent probes, thereby triggering the hybridization chain reaction (HCR), and then forming a stable DNA network. At the protection stage, the crosslinker crosslinks the hydrogel skeleton material to construct an effective hydrogel barrier and play a protective role. At the energy level stage, when the hydrogel is degraded, the DNA logic framework induces receptor dimerization, thereby activating the signal pathway and completing the entire functional activation process.
[0024] In the application, probe 1 and probe 2 are aptamer-spacer-toehold probes, the structure of probe 1 is Apt-S-T1, and the structure of probe 2 is T2-S-Apt, wherein Apt is a nucleic acid aptamer targeting the cell membrane receptor to be treated, S is a spacer sequence, and T1 and T2 are first and second toehold sequences, respectively. Apt is not particularly limited and can be customized based on the specific cell to be treated. In some specific examples of the application, the treated cells are Jurkat T cells, HeLa cells or PL45 cells, and a nucleic acid aptamer targeting the cell membrane receptor of the specific cell can be designed.
[0025] The first toehold sequence and the second toehold sequence are also not particularly limited, and those skilled in the art can design them accordingly as needed, which they are capable of. In some specific examples of the application, the nucleotide sequence of the first toehold sequence is CGACATCTAACCTGGCGTCCTTCAT (SEQ ID NO. 1); and the nucleotide sequence of the second toehold sequence is GACCCTAAGCATACATGCTCACTGACGCTAGG (SEQ ID NO. 2).
[0026] In the present application, the spacer S is a nucleotide sequence operably linked to the first and second toehold sequences and the aptamer targeting the cell membrane receptor to be treated, and its specific composition and length can be designed as needed without special restrictions, as long as it can ensure the functions of the first and second toehold sequences and the aptamer. In some specific examples, the nucleotide sequence of the spacer sequence is 15 bases long, and is TTTTTTTTTTTTTTT (SEQ ID NO. 3).
[0027] In the present application, the linker, hairpin 1 and hairpin 2 are designed according to the first and second toehold sequences without special restrictions. Among them, the linker is used to trigger the hybridization chain reaction to cause DNA self-assembly. In some specific examples, the nucleotide sequence of the linker is CTTACAACACCTAGCGTCAGTGAGCCCAGGTTAGATGTCG (SEQ ID NO. 4). The nucleotide sequence of the hairpin 1 is ATGAAGGACGATGTATGCTTAGGGTCGACTTCCATAGACCCTAAGCATACAT (SEQ ID NO. 5); and the nucleotide sequence of the hairpin 2 is GACCCTAAGCATACATCGTCCTTCATATGTATGCTTAGGGTCTATGGAAGTC (SEQ ID NO. 6).
[0028] However, it can be understood that the sequences of the toehold sequences, the spacer, the linker, the hairpin 1 and the hairpin 2 are not limited to the examples made in the present application, and those skilled in the art can make corresponding customization based on the cells to be treated, which has such ability.
[0029] Further, the hydrogel skeleton material is modified at the end of the hairpin 1 or the hairpin 2, which can be selected or designed as needed by those skilled in the art, for example, the hydrogel skeleton material can be modified at the end of the hairpin 1, or the hydrogel skeleton material can be modified at the end of the hairpin 2. Here, the end refers to both 5' or 3', which can be customized and designed according to the actual situation. The type of hydrogel skeleton material is not particularly limited, and any common hydrogel skeleton material in the art can be used, and specific examples include but are not limited to sodium alginate, chitosan and calcium hyaluronate, etc. In some examples, the hydrogel skeleton material is sodium alginate.
[0030] In the present application, the crosslinking agent in the artificial cell wall system is an auxiliary agent commonly used in the art for crosslinking hydrogel skeleton materials to form hydrogels, preferably a calcium salt, and is usually calcium chloride (CaCl2).
[0031] It can be understood that, in order to facilitate tracking or observing the process of DNA assembly and artificial cell wall formation and degradation, the ends of probe 1, probe 2, hairpin 1, hairpin 2, etc. can be modified with fluorescent labels, preferably, the fluorescent labels they are modified with are not the same as each other, thereby facilitating tracking and observation. In the present application, the fluorescent labels are not particularly limited, and any common or independently developed fluorescent label in the art can be used, and specific examples include but are not limited to cyanine dyes (such as Cy3, Cy5, Cy5.5, etc.), rhodamine derivatives (such as Texas Red, rhodamine, rhodamine B, etc.), fluoresceins (such as FAM, FITC, etc.), but are not limited thereto. These fluorescent labels are usually modified at the end of the sequence (5' or 3'), and can be designed as needed, and those skilled in the art have the ability to do so, so further description is not provided.
[0032] Further, the concentrations of the components in the artificial cell wall system in the present application are not particularly required, and can be determined by experimental methods. By adjusting and optimizing the concentrations of the components, the thickness of the artificial cell wall can be controlled, thereby being designed specifically for different cells to be treated. In some examples, the thickness of the artificial cell wall formed by the artificial cell wall system is 50-200 nm. As an example, the concentrations of the components in the artificial cell wall system are 400 nM of probe 1, 400 nM of probe 2, 400 nM of linker, 1 μM of hairpin 1, 1 μM of hairpin 2, and 2.5 mM of calcium chloride, and the hydrogel skeleton material modified at the end of hairpin 1 is sodium alginate.
[0033] The second aspect of the present application discloses the use of the artificial cell wall system as described in the first aspect of the present application in cell cryopreservation or cell regeneration. The artificial cell wall system in the present application is applied to cell cryopreservation, and the artificial cell wall is constructed based on DNA logic gate driving. Not only is DMSO-free cryopreservation achieved, but also the integrity of the cell membrane is protected during the freezing process. The subsequent recovered cells not only survive, but also have a proliferation capacity that exceeds that of fresh cells. This cryopreservation scheme has universality, and the probe sequence can be optimized or designed for different cell types to customize the corresponding artificial cell wall system, thereby meeting the cryopreservation needs of various cell types.
[0034] Further, the artificial cell wall system in the present application also has the effect of promoting wound healing, and can be applied to the field of cell regeneration.
[0035] The third aspect of the present application discloses a cell cryopreservation system, comprising: the artificial cell wall system as described in the first aspect of the present application; and a permeable cryoprotective additive with a concentration of not more than 10%, wherein the permeable cryoprotective additive is a polyol.
[0036] The polyhydric alcohol permeable cryoprotective additive described in the present application is a common type in the art, and specific examples are ethylene glycol, propylene glycol, or glycerol, etc. In some specific examples, the permeable cryoprotective additive is ethylene glycol. The artificial cell wall driven by the DNA logic gate cooperates with a low concentration of polyhydric alcohol permeable cryoprotective additive, thereby synergistically achieving efficient cryopreservation of cells.
[0037] The fourth aspect of the present application discloses a method for cryopreservation of cells, and the whole mechanism process of artificial cell wall system + cryoprotective agent for cell cryopreservation can be referred to Figure 1 , which comprises the following steps: The cells to be cryopreserved are cryopreserved in a cell culture medium containing the cell cryopreservation system described above. Specifically, the cells to be treated are incubated in the artificial cell wall system, and specific recognition and encapsulation of the cells are achieved by the associated toe end activation mechanism. First, probe 1 and probe 2 precisely target the target cells, and under the action of the linker, trigger the bridging of adjacent probes, and then trigger the hybridization chain reaction (HCR), and hairpin 1 and hairpin 2 self-assemble to form a branched DNA framework. Subsequently, the DNA framework guides the cross-linking of the cross-linking agent to cross-link the hydrogel skeleton material to form a physical barrier layer (hydrogel), which tightly wraps the cell membrane and effectively isolates the ice crystals, thereby reducing the osmotic shock. After the ACW is constructed, a polyhydric alcohol permeable cryoprotective additive with a final concentration of not more than 10% is added to the system, and after incubation at 4°C, the cells are cryopreserved. The specific freezing steps are conventional operations in the art, and as an example, the complex of the cryoprotective agent and the cells is first placed in a -80°C refrigerator overnight, and the system is ensured to complete the gradient cooling smoothly in a low-temperature environment at a cooling rate of -1 ℃ / min. After the overnight cooling process is completed, the cryopreservation tube is taken out of the programmed cooling box and quickly transferred to liquid nitrogen at -196°C, and stored under this condition for at least 24 hours to achieve long-term stable preservation of the complex.
[0038] Further, the method further comprises the step of cell thawing and recovery, which comprises the step of thawing the cryopreserved cells in a 37°C water bath, and the specific time should not be too long, preferably ≤60s, to prevent recrystallization.
[0039] Further, the method further comprises the step of cell function activation, which comprises the following steps: After centrifugation of the mixture after thawing and recovery of the cryopreserved cells, the hydrogel is degraded while the DNA framework is retained, and the cells are washed by centrifugation. Specifically, after the degradation of the hydrogel, the function is activated by activating the signal pathway (D) in Figure 1 , the DNA framework can induce receptor dimerization, thereby activating Akt phosphorylation and restoring cell function.
[0040] In some examples, the degradation of the artificial cell wall employs 0.1M sodium citrate.
[0041] In addition, according to the experimental results of the present application, it is found that after the degradation of the hydrogel, the DNA logic framework can also be selectively degraded, and after the degradation of the DNA logic framework, the cell proliferation ability is basically the same as that of fresh cells. Whether to degrade or not can be selected by those skilled in the art according to the needs.
[0042] The present application will be further illustrated below with specific examples. It should be noted that the following specific examples are for illustrative purposes only and do not limit the scope of the present application in any way.
[0043] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this application belongs. The terminology used in the description herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the present application.
[0044] In addition, unless otherwise specified, the methods without specific conditions or steps are conventional methods, and the reagents and materials used can be obtained from commercial channels.
[0045] 1. Material preparation Jurkat T cells: CL-0129, Wuhan Punuo Life Science Co., Ltd.
[0046] HeLa cells: Shanghai Wei'ai Biological Technology Co., Ltd.
[0047] PL45 cells: SC0189, Yuli (Shanghai) Biological Technology Co., Ltd.
[0048] Cell culture: the cells were cultured in the corresponding culture medium, and when the viable cell density reached about 1.0×10 6 cells / mL in the cell culture bottle, they were detached from the bottom of the bottle by adding trypsin digestion solution, and the Jurkat T cells were directly used after centrifugation.
[0049] Cell culture medium: DMEM (KGM12800-500, Nanjing Kaygen Biotech Co., Ltd.), used for culturing HeLa cells and PL45 cells; RPMI 1640 (11875805, Thermo Fisher Scientific), used for culturing Jurkat T cells.
[0050] Example 1 In this embodiment, Jurkat T cells were used as an example for cell cryopreservation.
[0051] The artificial cell wall system is composed of the sequences shown in Table 1. Table 1 Artificial cell wall system
[0052] The sequence information involved in the artificial cell wall system is shown in Table 2: Table 2 Sequence information
[0053] Note: For subsequent research characterization, the 5' of probe 1 is modified with FAM, the 3' of probe 2 is modified with Cy3, and the 5' of hairpin H2 is modified with Cy5. No labeling is required in actual application.
[0054] 1.2 Cryopreservation of Jurkat T cells Step 1: ACW construction Take the cultured Jurkat T cells, add 400 nM of probe 1, 400 nM of probe 2, 400 nM of linker, 1 μM of H1-Alg, and 1 μM of H2-Cy5 probe, and the solution system is RPMI 1640 medium (200 μL). Incubate at 4°C for 1 hour to trigger self-assembly and hybridization chain reaction occurs; then add CaCl2 (2.5 mM) to induce sodium alginate gelation and form ACW. To facilitate observation of the construction of ACW, a non-ACW group without crosslinking agent is also set up.
[0055] Step 2: Cryopreservation After the construction of ACW is completed, add 10% (volume fraction) ethylene glycol to the system containing the cell-ACW complex, and incubate in a shaking bed at 4°C to ensure uniform distribution of the cryoprotective agent around the complex. Transfer the cryopreservation tube to a programmed cooling box, then place the whole into a pre-cooled refrigerator at -80°C overnight. Ensure that the system completes the gradient cooling smoothly in the low-temperature environment at a cooling rate of -1°C / min. After the overnight cooling process is completed, remove the cryopreservation tube from the programmed cooling box, quickly transfer it to liquid nitrogen at -196°C, and store it under this condition for at least 24 hours to achieve long-term stable preservation of the complex.
[0056] Two control groups are set up at the same time. Control group 1: natural cells containing only medium; control group 2: natural cells with only 10% ethylene glycol added to the reaction system.
[0057] Step 3: Cell recovery Quickly thaw the cryopreservation tube in a 37°C water bath for 1 minute to recover the cells.
[0058] Among them, the combination Figure 1 and Figure 2 , Figure 2This illustrates the characterization of the DNA logical framework on the target cell membrane during the self-assembly triggering process ( Figure 1 China A and Figure 1 The process of connecting the two molecules (B, C, and D) is carried out, with the linker simultaneously hybridizing T1 and T2, activating the strand substitution reaction, and subsequently opening the sodium alginate-modified hairpin (H1-Alg) and Cy5-labeled hairpin (H2), forming a branched DNA network. Figure 2 (B) Combined with verification ( Figure 2 C and D) strongly demonstrate the effectiveness of this step; flow cytometry shows that the TCO1 aptamer can target Jurkat T cells ( Figure 2 In the middle (C), under a fluorescence microscope, FAM-labeled TCO1-S-T1 (green) and Cy3-labeled T2-S-TCO1 (magenta) achieved co-localization, as did Cy5-labeled H2 (red), demonstrating that the DNA logical framework is assembled on the cell membrane surface.
[0059] pass Figure 3 It can be seen that the ACW group formed a physical barrier layer outside Jurkat T cells, which was formed by calcium ion cross-linking of sodium alginate guided by the DNA framework, and the thickness of the hydrogel layer was 50~200nm. Figure 3 (C and D), this process was shown by Calcein staining to enrich Ca²⁺ ( Figure 3 (A and B) and electron microscopy confirmed the dense layered structure ( Figure 3 C and D) were verified. This ACW structure plays a crucial role in cryoprotection, with its cryoprotection mechanism encompassing both physical barriers and osmotic regulation. Physically, the hydrogel prevents ice crystals from penetrating the cell membrane; osmotically, the hollow channels of the DNA framework allow intracellular water to drain, reducing cryoexpansion damage. This will be confirmed through subsequent results.
[0060] Example 2 In this embodiment, HeLa cells were used as an example for cell cryopreservation.
[0061] The specific steps are the same as in Example 1, except that probe 1 and probe 2 are different. All other process steps and parameters are the same as in Example 1. In this example, corresponding functional activation was performed after HeLa cell resuscitation, and the specific steps are as follows: After thawing, the mixture in the cryopreservation tube was transferred to a 2 mL test tube containing 1 mL of culture medium and centrifuged at 900 rpm for 5 minutes; ACW was degraded with 0.1 M sodium citrate, while retaining the DNA logical framework; the cells were washed three times after centrifugation.
[0062] In addition, in order to study the role of DNA logical frameworks in cell proliferation, this application also conducted an experimental group of DNA logical frameworks degraded with DNase I after degrading the hydrogel.
[0063] In this embodiment, the sequences of probe 1 and probe 2 are as follows, respectively: Probe 1: ATCAGGCTGGATGGTAGCTCGGTCGGGGTGGGTGGGTTGGCAAGTCTGATTTTTTTTTTTTTTTTCGACATCTAACCTGGCGTCCTTCAT.
[0064] Probe 2: GACCCTAAGCATACATGCTCACTGACGCTAGGTTTTTTTTTTTTTTTATCAGGCTGGATGGTAGCTCGGTCGGGGTGGGTGGGTTGGCAAGTCTGAT.
[0065] Example 3 In this embodiment, the PL45 cells are taken as an example to perform the cell cryopreservation. The specific steps refer to the same implementation manner of Example 1, and the only difference is that the probe 1 and the probe 2 are different. The other process steps and parameter conditions are the same as those of Example 1.
[0066] In this embodiment, the sequences of probe 1 and probe 2 are as follows, respectively: Probe 1: ATCAGGCTGGATGGTAGCTCGGTCGGGGTGGGTGGGTTGGCAAGTCTGATTTTTTTTTTTTTTTTCGACATCTAACCTGGCGTCCTTCAT.
[0067] Probe 2: GACCCTAAGCATACATGCTCACTGACGCTAGGTTTTTTTTTTTTTTTACTCATAGGGTTAGGGGCTGCTGGCCAGATACTCAGATGGTAGGGTTACTATGAGC.
[0068] Example 4 In this embodiment, the cells cryopreserved in Examples 1-3 are respectively characterized in terms of cell physicochemical properties, physiological functions and ACW cell regulation.
[0069] 4.1 Characterization of cell physicochemical properties and physiological functions Figure 4The physicochemical properties and physiological functions of Jurkat T cells, HeLa cells, and PL45 cells after cryopreservation in Examples 1-3 are shown in Table 1. As can be seen, during the cryopreservation process, naked cells are susceptible to mechanical damage caused by ice crystal penetration and osmotic stress caused by solute concentration gradients. In contrast, ACW-protected cells exhibit significantly enhanced cryoresistance Figure 4 Table 1A. The survival rates of the three cells after thawing were also tested. The survival rates of the Jurkat T cells, HeLa cells, and PL45 cells cryopreserved with ACW and 10% ethylene glycol (EG) were 84%, 68%, and 68%, respectively, which were significantly higher than those of the cells treated with EG alone (32%, 21%, and 48%, respectively). The survival rates of the three cells after cryopreservation were increased by 162.5%, 223.8%, and 41.7%, respectively Figure 4 Table 1B-D.
[0070] Further, the recovery after thawing was quantified by the adhesion efficiency experiment. After 24 hours of cryopreservation, cell viability was further evaluated by the adhesion efficiency (the ratio of cryopreserved adherent cells to fresh control cells), and the results are continued in Table 2 Figure 4 Notably, the Jurkat T cells treated with ACW exhibited similar natural cluster-like growth to fresh cells, while the cells cryopreserved with 10% EG alone were morphologically damaged Figure 4 Table 2E. Quantitative results analysis showed that the adhesion efficiency of HeLa cells and PL45 cells in the ACW group was 91.7 ± 6.6% and 77 ± 9.5%, respectively, which was significantly higher than that of the 10% EG control group (60.7 ± 7.1% and 57.6 ± 4.9%, respectively) Figure 4 Table 2F-G.
[0071] The above results show that ACW not only maintains cell viability but also preserves function after thawing, which is a key advantage for therapeutic applications that require rapid recovery of cells. It was also found that HeLa cells treated with the DNA logic framework exhibited extremely high adhesion efficiency (> 90%) and a 223.8% increase in survival rate, which suggests that the DNA logic framework may play an important role in regulating receptor-driven signaling pathways.
[0072] 4.2 Flow cytometry evaluation of immediate cell viability after cryopreservation The immediate cell viability after cryopreservation was evaluated by flow cytometry to examine cell membrane integrity, and the specific steps are as follows: (1) The frozen cells were quickly thawed in a 37°C water bath for about 1 minute. After that, the mixture in the cryo-preservation tube was transferred to a 2 mL tube containing 1 mL of culture medium and centrifuged at 900 rpm for 5 minutes. ACW was degraded with 0.1 M sodium citrate while preserving the DNA logical framework; meanwhile, an additional experimental group was performed to degrade the DNA logical framework with DNase I. After all the degradation was completed, the cells were washed three times after centrifugation.
[0073] According to the instructions, the cells were incubated with a certain concentration of PI staining solution at 37°C for 10 minutes. After that, the cells were washed three times again, the cell pellet was suspended in 200 μL of binding buffer, and flow cytometry was performed within 10 minutes at the appropriate temperature.
[0074] The real-time viability of these cells was then determined using the BD Accuri™ C6 by counting 10000 events. The relative enhancement rate (RER) was calculated according to formula (1):
[0075] (2) To quantify cell adhesion efficiency and cell growth to assess long-term cell viability, the cell suspension in one cryo-preservation tube after freezing was centrifuged and resuspended in 1 mL of culture medium. Then, the cell suspension was pipetted into one well of a 6-well plate and cultured in a 37°C, 5% CO2 incubator. The control group was the same number of fresh cells from the same batch and cultured in the same 6-well plate. Then the supernatant was removed by aspiration and the cells were washed with 1x PBS before being digested with trypsin / EDTA. Finally, the cells were counted using a hemocytometer and the cell adhesion efficiency was quantified as the ratio of the number of experimental cells to the number of control cells.
[0076] (3) To quantify cell proliferation, the cells after freezing preservation under different conditions were seeded in a 6-well plate. After 1 day of culture, the cells were digested and seeded in a 6-well plate at a density of 1x10 5 cells / well. At different times (1st, 2nd and 3rd days), the cells were digested and the number of cells was counted using a hemocytometer. The proliferation was calculated as the ratio of the number of cells on the 2nd and 3rd days to the initial number of cells on the 1st day.
[0077] 4.3 Wound healing experiment (scratch test) of HeLa cell migration in vitro Cells were rewarmed and cultured overnight in 6-well plates to allow them to adhere. The medium containing 10% fetal bovine serum was then replaced with medium containing 2% fetal bovine serum to exclude the interference of cytokines on migration. The confluent HeLa cell monolayer was then wounded with a 200 μL tip. Images were taken at 0, 24, and 48 hours after wounding, and the percentage of cell migration rate was measured using Image J software and expressed as the ratio of the area covered by cells within the wound to the initial cell-free area. Western blot analysis was also used to detect p-Akt levels.
[0078] 4.2 Items -4.3 Items Results as shown in Figure 5 , it can be concluded that the activation of MET receptor triggers autophosphorylation, which in turn activates the MET signaling pathway and downstream signal transduction cascade, in which promoting cell migration is an important manifestation Figure 5 . After making artificial wounds on the HeLa cell monolayer, wound healing was recorded and analyzed, and the results showed that the wound closure rate of cells treated with DNA logic framework was 52.2%, which was 127.9% higher than that of fresh cell group Figure 5 . Western blot analysis further supported this finding, indicating that MET and downstream Akt were significantly phosphorylated in DNA framework-treated cells. Notably, this phosphorylation was attenuated when the framework was degraded, confirming that the DNA logic framework drives MET dimerization and subsequent signal activation Figure 5 . B and Figure 5 . E) HeLa cells treated with DNA logic framework, the proliferation rate was increased by 28.2% compared with the untreated control group Figure 5 . F).
[0079] It should be noted that the present application is not limited to the above-mentioned embodiments. The above-mentioned embodiments are only examples, and embodiments having the same technical idea and playing the same role and effect within the scope of the technical solution of the present application are all included in the technical scope of the present application. In addition, within the scope of the main idea of the present application, various modifications that can be thought of by those skilled in the art, other ways constructed by combining part of the components of the embodiments are also included in the scope of the present application.
Claims
1. An artificial cell wall system based on DNA logic gates, characterized in that, include: Probe 1 and probe 2, probe 1 has the structure Apt-S-T1 and probe 2 has the structure T2-S-Apt, where Apt is a nucleic acid aptamer targeting the cell membrane receptor to be treated, S is the spacer region sequence, and T1 and T2 are the first and second toe terminal sequences, respectively. Linkers are used to trigger a hybridization chain reaction to form a stable DNA structure; Hair clip 1 and hair clip 2, wherein the ends of hair clip 1 or hair clip 2 are modified with hydrogel skeleton material; And crosslinking agents used to initiate the crosslinking of hydrogel framework materials to form hydrogels.
2. The artificial cell wall system as described in claim 1, characterized in that, The nucleotide sequence of the first toe-end sequence is shown in SEQ ID NO.1; The nucleotide sequence of the second toe-end sequence is shown in SEQ ID NO.2; The nucleotide sequence of the linker is shown in SEQ ID NO.4; The nucleotide sequence of the hairpin 1 is shown in SEQ ID NO. 5; The nucleotide sequence of the hairpin 2 is shown in SEQ ID NO.
6.
3. The artificial cell wall system as described in claim 1, characterized in that, The nucleotide sequence of the spacer region is shown in SEQ ID NO.
3.
4. The artificial cell wall system as described in claim 1, characterized in that, The hydrogel framework material is sodium alginate; the crosslinking agent is calcium chloride.
5. The artificial cell wall system as described in claim 1, characterized in that, The thickness of the artificial cell wall formed by the targeted encapsulation of the artificial cell wall system is 50~200nm.
6. The application of the artificial cell wall system as described in any one of claims 1-5 in cell cryopreservation or cell regeneration.
7. A cell cryopreservation system, characterized in that, include: The artificial cell wall system according to any one of claims 1-5; And a permeable cryoprotectant additive with a concentration not exceeding 10%, wherein the permeable cryoprotectant additive is a polyol.
8. A method for cryopreservation of cells, characterized in that, Includes the following steps: The cells to be cryopreserved are cryopreserved at low temperature in a cell culture medium containing the cell cryopreservation system of claim 7.
9. The cell cryopreservation method as described in claim 8, characterized in that, It also includes a cell thawing and resuscitation step, which includes thawing the frozen cells in a 37°C water bath.
10. The cell cryopreservation method as described in claim 9, characterized in that, It also includes a cell function activation step, which includes the following steps: After thawing and resuscitating the frozen cells, the mixture was centrifuged to degrade the hydrogel, and the cells were washed by centrifugation. Preferably, 0.1M sodium citrate is used to degrade the hydrogel.
